James J. Ferguson
2021
In 2021, James J. Ferguson earned a total compensation of $1.6M as Chief Medical Officer at Matinas BioPharma Holdings, a 2% decrease compared to previous year.
Compensation breakdown
| Bonus | $164,000 |
|---|---|
| Option Awards | $1,035,637 |
| Salary | $422,300 |
| Total | $1,621,937 |
Ferguson received $1M in option awards, accounting for 64% of the total pay in 2021.
Ferguson also received $164K in bonus and $422.3K in salary.
Rankings
In 2021, James J. Ferguson's compensation ranked 6,917th out of 12,405 executives tracked by ExecPay. In other words, Ferguson earned more than 44.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,917 out of 12,405 | 44th |
Division Manufacturing | 3,020 out of 5,494 | 45th |
Major group Chemicals And Allied Products | 1,338 out of 2,369 | 44th |
Industry group Drugs | 1,194 out of 2,090 | 43rd |
Industry Pharmaceutical Preparations | 868 out of 1,537 | 44th |
Source: SEC filing on September 22, 2022.
Ferguson's colleagues
We found two more compensation records of executives who worked with James J. Ferguson at Matinas BioPharma Holdings in 2021.